Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q4355941> ?p ?o }
Showing triples 1 to 52 of
52
with 100 triples per page.
- Q4355941 subject Q8220082.
- Q4355941 subject Q8703495.
- Q4355941 subject Q8727262.
- Q4355941 subject Q8844620.
- Q4355941 subject Q8965786.
- Q4355941 subject Q9052323.
- Q4355941 abstract "Almorexant (INN, codenamed ACT-078573) is an orexin antagonist, functioning as a competitive receptor antagonist of the OX1 and OX2 orexin receptors, which was being developed by the pharmaceutical companies Actelion and GSK for the treatment of insomnia. Development of the drug was abandoned in January 2011.".
- Q4355941 atcPrefix "none".
- Q4355941 casNumber "871224-64-5".
- Q4355941 fdaUniiCode "9KCW39P2EI".
- Q4355941 iupacName "(2R)-2-[(1S)- 6,7-dimethoxy- 1-{2-[4-(trifluoromethyl)phenyl]ethyl}- 3,4-dihydroisoquinolin-2(1H)-yl]- N-methyl- 2-phenylacetamide".
- Q4355941 pubchem "23727689".
- Q4355941 thumbnail Almorexant.svg?width=300.
- Q4355941 wikiPageExternalLink www.actelion.com.
- Q4355941 wikiPageWikiLink Q12140.
- Q4355941 wikiPageWikiLink Q135761.
- Q4355941 wikiPageWikiLink Q18355303.
- Q4355941 wikiPageWikiLink Q1869874.
- Q4355941 wikiPageWikiLink Q20707990.
- Q4355941 wikiPageWikiLink Q212322.
- Q4355941 wikiPageWikiLink Q2198549.
- Q4355941 wikiPageWikiLink Q30612.
- Q4355941 wikiPageWikiLink Q343217.
- Q4355941 wikiPageWikiLink Q410857.
- Q4355941 wikiPageWikiLink Q410943.
- Q4355941 wikiPageWikiLink Q706.
- Q4355941 wikiPageWikiLink Q7101688.
- Q4355941 wikiPageWikiLink Q7388914.
- Q4355941 wikiPageWikiLink Q7650517.
- Q4355941 wikiPageWikiLink Q8220082.
- Q4355941 wikiPageWikiLink Q824258.
- Q4355941 wikiPageWikiLink Q83871.
- Q4355941 wikiPageWikiLink Q8703495.
- Q4355941 wikiPageWikiLink Q8727262.
- Q4355941 wikiPageWikiLink Q8844620.
- Q4355941 wikiPageWikiLink Q8965786.
- Q4355941 wikiPageWikiLink Q9052323.
- Q4355941 wikiPageWikiLink Q9368.
- Q4355941 atcPrefix "none".
- Q4355941 casNumber "871224".
- Q4355941 iupacName "-2".
- Q4355941 pubchem "23727689".
- Q4355941 unii "9".
- Q4355941 type ChemicalSubstance.
- Q4355941 type Drug.
- Q4355941 type ChemicalObject.
- Q4355941 type Thing.
- Q4355941 type Q8386.
- Q4355941 comment "Almorexant (INN, codenamed ACT-078573) is an orexin antagonist, functioning as a competitive receptor antagonist of the OX1 and OX2 orexin receptors, which was being developed by the pharmaceutical companies Actelion and GSK for the treatment of insomnia. Development of the drug was abandoned in January 2011.".
- Q4355941 label "Almorexant".
- Q4355941 depiction Almorexant.svg.
- Q4355941 homepage www.actelion.com.